Status:
COMPLETED
Approach Bias Retraining to Augment Smoking Cessation
Lead Sponsor:
University of Texas at Austin
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Nicotine Dependence
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Tobacco use is the most preventable cause of disease, disability, and death in the United States. Standard smoking cessation care (cognitive behavioral therapy and nicotine replacement therapy), is ef...
Detailed Description
The integrated intervention involves seven weekly 60-minute therapy sessions. The each therapy session involves 15 minutes of computerized approach bias retraining and 45 minutes of individual cogniti...
Eligibility Criteria
Inclusion
- Male and female patients ages 18-65 capable of providing informed consent
- Willing and able to provide informed consent, attend all study visits, and comply with the protocol
- Daily smoker for at least 1 year
- Currently smoke an average of at least 5 cigarettes per day
- Report a motivation to quit smoking of at least 5 on a 10-point scale
Exclusion
- A lifetime history of bipolar disorder, schizophrenia, psychosis, or delusional disorders; an eating disorder in the past 6 months; organic brain syndrome, mental retardation or other cognitive dysfunction that could interfere with capacity to engage in therapy; a history of substance or alcohol abuse or dependence (other than nicotine) in the last 6 months or otherwise unable to commit to refraining from alcohol use during the acute period of study participation.
- Visual or hand-motoric impairments
- Current use of nicotine replacement therapy
- Current use of any other pharmacotherapy or psychotherapy for smoking cessation not provided by the researchers during the quit attempt
- Current use of tobacco products other than cigarettes
- Insufficient command of the English language as the treatment manual is written only in English and study staff are not fluent in other languages
Key Trial Info
Start Date :
November 29 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 8 2021
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT03325777
Start Date
November 29 2017
End Date
October 8 2021
Last Update
June 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Texas at Austin
Austin, Texas, United States, 78712